 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
argenx SE
ARGX
|
311 |
$ 834.06 |
0.94 % |
$ 25 B |
Niderland |
 |
Ascendis Pharma A/S
ASND
|
947 |
$ 234.24 |
-0.3 % |
$ 5 B |
Danmark |
 |
Harmony Biosciences Holdings
HRMY
|
1.85 |
$ 27.99 |
4.17 % |
$ 1.59 B |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Aptorum Group Limited
APM
|
105 |
$ 0.81 |
1.31 % |
$ 4.42 M |
China |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
AIkido Pharma
AIKI
|
1.08 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.33 |
0.79 % |
$ 8.01 B |
Australia |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Atea Pharmaceuticals
AVIR
|
2.11 |
$ 4.66 |
1.42 % |
$ 393 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Biogen
BIIB
|
2.97 |
$ 194.87 |
-0.75 % |
$ 28.5 B |
USA |
 |
Bellicum Pharmaceuticals
BLCM
|
5.55 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
BioMarin Pharmaceutical
BMRN
|
4.6 |
$ 63.02 |
0.15 % |
$ 12 B |
USA |
 |
Baudax Bio
BXRX
|
0.614 |
- |
0.59 % |
$ 63 K |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
1.34 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 110.88 |
0.86 % |
$ 27.2 B |
Germany |
 |
Amneal Pharmaceuticals
AMRX
|
0.654 |
$ 14.72 |
2.08 % |
$ 4.55 B |
USA |
 |
Calithera Biosciences
CALA
|
98.5 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Arena Pharmaceuticals
ARNA
|
105 K |
- |
-6.81 % |
$ 3.04 B |
USA |